Literature DB >> 30945973

Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages.

Chaitrali Saha1,2, Prathap Kothapalli1, Veerupaxagouda Patil1, Gundallahalli Bayyappa ManjunathaReddy1,3, Srini V Kaveri1, Jagadeesh Bayry1.   

Abstract

Intravenous immunoglobulin (IVIG) is one of the widely used immunotherapeutic molecules in the therapy of autoimmune and inflammatory diseases. Previous reports demonstrate that one of the anti-inflammatory actions of IVIG implicates suppression of macrophage activation and release of their inflammatory mediators. However, macrophages are highly plastic and depending on the microenvironmental signals, macrophages can be polarized into pro-inflammatory classic (M1) or anti-inflammatory alternative (M2) type. This plasticity of macrophages raised additional questions on the role of IVIG towards macrophage polarization. In the present report, we show that IVIG affects the polarization of both classically and alternatively activated macrophages and this process is F(ab')2-independent. Our data thus indicate the lack of reciprocal regulation of inflammatory and non-inflammatory macrophages by IVIG.

Keywords:  IVIG; IgG; inflammation; innate cells; macrophage; monocyte

Year:  2019        PMID: 30945973      PMCID: PMC7062444          DOI: 10.1080/21645515.2019.1602434

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  46 in total

1.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis.

Authors:  Shivashankar Othy; Pushpa Hegde; Selma Topçu; Meenu Sharma; Mohan S Maddur; Sebastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Immunol       Date:  2013-03-22       Impact factor: 5.422

3.  Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin.

Authors:  Mohan S Maddur; Srini V Kaveri; Jagadeesh Bayry
Journal:  Trends Immunol       Date:  2017-09-12       Impact factor: 16.687

Review 4.  Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies.

Authors:  Cristina João; Vir Singh Negi; Michel D Kazatchkine; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Immunol       Date:  2018-03-15       Impact factor: 5.422

5.  Regulatory T cells induce activation rather than suppression of human basophils.

Authors:  Meenu Sharma; Mrinmoy Das; Emmanuel Stephen-Victor; Caroline Galeotti; Anupama Karnam; Mohan S Maddur; Patrick Bruneval; Srini V Kaveri; Jagadeesh Bayry
Journal:  Sci Immunol       Date:  2018-05-25

6.  Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin.

Authors:  J K Damås; L Gullestad; H Aass; S Simonsen; J G Fjeld; L Wikeby; T Ueland; H G Eiken; S S Frøland; P Aukrust
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

7.  Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization.

Authors:  Angeles Domínguez-Soto; Mateo de las Casas-Engel; Rafael Bragado; José Medina-Echeverz; Laura Aragoneses-Fenoll; Enrique Martín-Gayo; Nico van Rooijen; Pedro Berraondo; María L Toribio; María A Moro; Isabel Cuartero; Antonio Castrillo; David Sancho; Carmen Sánchez-Torres; Pierre Bruhns; Silvia Sánchez-Ramón; Angel L Corbí
Journal:  J Immunol       Date:  2014-10-17       Impact factor: 5.422

Review 8.  Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye.

Authors:  Angela S W Tjon; Rogier van Gent; Teunis B Geijtenbeek; Jaap Kwekkeboom
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

9.  The Future of Immunotherapy: A 20-Year Perspective.

Authors:  David C Wraith
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

10.  IVIg and LPS Co-stimulation Induces IL-10 Production by Human Monocytes, Which Is Compromised by an FcγRIIA Disease-Associated Gene Variant.

Authors:  Lisa K Kozicky; Susan C Menzies; Zheng Yu Zhao; Tariq Vira; Kiera Harnden; Kwestan Safari; Kate L Del Bel; Stuart E Turvey; Laura M Sly
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

View more
  2 in total

Review 1.  Macrophage Polarization and Plasticity in Systemic Lupus Erythematosus.

Authors:  Mariame Mohamed Ahamada; Yang Jia; Xiaochuan Wu
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

Review 2.  Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease.

Authors:  Maria Giovanna Danieli; Mario Andrea Piga; Alberto Paladini; Eleonora Longhi; Cristina Mezzanotte; Gianluca Moroncini; Yehuda Shoenfeld
Journal:  Scand J Immunol       Date:  2021-09-16       Impact factor: 3.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.